Literature DB >> 10407774

Inborn errors of neurotransmitter receptors.

R Surtees1.   

Abstract

Inborn errors of neurotransmitter receptors are recently described gene mutations that directly affect receptor function. Currently three conditions are known to be caused by this mechanism: hyperekplexia; two forms of congenital inherited myasthenic syndromes; and autosomal dominant nocturnal frontal lobe epilepsy. Here, neurotransmitters, their receptors and known inborn errors of receptor function are reviewed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407774     DOI: 10.1023/a:1005591820414

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

1.  A GLRA1 null mutation in recessive hyperekplexia challenges the functional role of glycine receptors.

Authors:  W Brune; R G Weber; B Saul; M von Knebel Doeberitz; C Grond-Ginsbach; K Kellerman; H M Meinck; C M Becker
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

2.  Hyperekplexia as cause of abnormal intrauterine movements.

Authors:  R J Leventer; I J Hopkins; L K Shield
Journal:  Lancet       Date:  1995-02-18       Impact factor: 79.321

3.  Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome.

Authors:  R Croxen; C Newland; D Beeson; H Oosterhuis; G Chauplannaz; A Vincent; J Newsom-Davis
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

4.  Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations.

Authors:  K Ohno; P A Quiram; M Milone; H L Wang; M C Harper; J N Pruitt; J M Brengman; L Pao; K H Fischbeck; T O Crawford; S M Sine; A G Engel
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

5.  Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit.

Authors:  K Ohno; H L Wang; M Milone; N Bren; J M Brengman; S Nakano; P Quiram; J N Pruitt; S M Sine; A G Engel
Journal:  Neuron       Date:  1996-07       Impact factor: 17.173

6.  A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  O K Steinlein; J C Mulley; P Propping; R H Wallace; H A Phillips; G R Sutherland; I E Scheffer; S F Berkovic
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

7.  Exon-intron structure of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4).

Authors:  O Steinlein; S Weiland; J Stoodt; P Propping
Journal:  Genomics       Date:  1996-03-01       Impact factor: 5.736

Review 8.  Congenital myasthenic syndromes.

Authors:  A G Engel
Journal:  Neurol Clin       Date:  1994-05       Impact factor: 3.806

9.  Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit.

Authors:  K Ohno; D O Hutchinson; M Milone; J M Brengman; C Bouzat; S M Sine; A G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

Review 10.  Genetics of the epilepsies.

Authors:  F Elmslie; M Gardiner
Journal:  Curr Opin Neurol       Date:  1995-04       Impact factor: 5.710

View more
  2 in total

1.  Dopamine-Responsive Growth-Hormone Deficiency and Central Hypothyroidism in Sepiapterin Reductase Deficiency.

Authors:  Matthias Zielonka; Nawal Makhseed; Nenad Blau; Markus Bettendorf; Georg Friedrich Hoffmann; Thomas Opladen
Journal:  JIMD Rep       Date:  2015-05-26

2.  Sepiapterin reductase deficiency in a 2-year-old girl with incomplete response to treatment during short-term follow-up.

Authors:  K Kusmierska; E E W Jansen; C Jakobs; K Szymanska; E Malunowicz; D Meilei; B Thony; N Blau; J Tryfon; D Rokicki; E Pronicka; J Sykut-Cegielska
Journal:  J Inherit Metab Dis       Date:  2009-01-07       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.